Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (LLY)
NYSE:LLY
LLY Analyst Ratings
Strong Buy
19 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LLY Stock 12 Month Forecast
Average Price Target
$1,038.21
▲(41.75% Upside)
| Highest Price Target$1,190 | Average Price Target$1,038 | Lowest Price Target$888.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
04/09/25
Morgan Stanley
Reiterated
04/09/25
Citi
Reiterated
04/08/25
Goldman Sachs
Upgraded
04/08/25
Leerink Partners
Reiterated
04/04/25
TD Cowen
Reiterated
04/02/25
Wells Fargo
Reiterated
03/31/25
Bernstein
Reiterated
03/25/25
Jefferies
Reiterated
03/24/25
Berenberg Bank
$970
Buy
32.44%
Upside
Reiterated
03/21/25
Eli Lilly & Co (LLY) Receives a Buy from Berenberg Bank
J.P. Morgan
$1,100
Buy
50.19%
Upside
Reiterated
02/26/25
Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE), Eli Lilly & Co (NYSE: LLY) and Vaxcyte (NASDAQ: PCVX)
Deutsche Bank
$1,010
Buy
37.90%
Upside
Reiterated
02/26/25
Deutsche Bank reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. InvestmentDeutsche Bank analyst James Shin reiterated a Buy rating and $1,010.00 price target on Eli Lilly (NYSE: LLY) after the company said it plans to double its U.S. manufacturing investment.
Truist Financial
―
Buy
―
Reiterated
02/26/25
Truist Financial Keeps Their Buy Rating on Eli Lilly & Co (LLY)
BMO Capital
$1,010
Buy
37.90%
Upside
Reiterated
02/25/25
Eli Lilly & Co's Strategic Expansion and Growth Prospects Drive Buy Rating
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
04/09/25
Morgan Stanley
Reiterated
04/09/25
Citi
Reiterated
04/08/25
Goldman Sachs
Upgraded
04/08/25
Leerink Partners
Reiterated
04/04/25
TD Cowen
Reiterated
04/02/25
Wells Fargo
Reiterated
03/31/25
Bernstein
Reiterated
03/25/25
Jefferies
Reiterated
03/24/25
Berenberg Bank
$970
Buy
32.44%
Upside
Reiterated
03/21/25
Eli Lilly & Co (LLY) Receives a Buy from Berenberg Bank
J.P. Morgan
$1,100
Buy
50.19%
Upside
Reiterated
02/26/25
Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE), Eli Lilly & Co (NYSE: LLY) and Vaxcyte (NASDAQ: PCVX)
Deutsche Bank
$1,010
Buy
37.90%
Upside
Reiterated
02/26/25
Deutsche Bank reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. InvestmentDeutsche Bank analyst James Shin reiterated a Buy rating and $1,010.00 price target on Eli Lilly (NYSE: LLY) after the company said it plans to double its U.S. manufacturing investment.
Truist Financial
―
Buy
―
Reiterated
02/26/25
Truist Financial Keeps Their Buy Rating on Eli Lilly & Co (LLY)
BMO Capital
$1,010
Buy
37.90%
Upside
Reiterated
02/25/25
Eli Lilly & Co's Strategic Expansion and Growth Prospects Drive Buy Rating
Best Analysts Covering Eli Lilly & Co
Which Analyst Should I Follow If I Want to Buy LLY and Sell After:
1 Month
xxx
Success Rate
28/36 ratings generated profit
Average Return
+5.63%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 77.78% of your transactions generating a profit, with an average return of +5.63% per trade.
3 Months
xxx
Success Rate
27/36 ratings generated profit
Average Return
+10.28%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +10.28% per trade.
1 Year
Success Rate
29/36 ratings generated profit
Average Return
+35.36%
reiterated a buy rating 2 months ago
Copying Chris Schott's trades and holding each position for 1 Year would result in 80.56% of your transactions generating a profit, with an average return of +35.36% per trade.
2 Years
xxx
Success Rate
25/28 ratings generated profit
Average Return
+31.93%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 89.29% of your transactions generating a profit, with an average return of +31.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LLY Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
1
2
2
1
1
Buy
51
49
60
63
45
Hold
3
5
2
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
55
56
64
66
46
Each month's total comprises the sum of three months' worth of ratings.
LLY Financial Forecast
LLY Stock Forecast FAQ
What is LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is $1,038.21.
What is LLY’s upside potential, based on the analysts’ average price target?
Eli Lilly & Co has 41.75% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LLY a Buy, Sell or Hold?
Eli Lilly & Co has a consensus rating of Strong Buy which is based on 19 buy ratings, 1 hold ratings and 0 sell ratings.
What is Eli Lilly & Co’s price target?
The average price target for Eli Lilly & Co is $1,038.21. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,190.00 ,the lowest forecast is $888.00. The average price target represents 41.75% Increase from the current price of $732.41.
The highest analyst price target is $1,190.00 ,the lowest forecast is $888.00. The average price target represents 41.75% Increase from the current price of $732.41.
What do analysts say about Eli Lilly & Co?
Eli Lilly & Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of LLY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.